Cargando…
The role of Lipoxin A4 in Cystic Fibrosis Lung Disease
In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl(−) secretion and Na(+) hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology (RNCSB) Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962119/ https://www.ncbi.nlm.nih.gov/pubmed/24688726 http://dx.doi.org/10.5936/csbj.201303018 |
_version_ | 1782308385914355712 |
---|---|
author | Urbach, Valérie Higgins, Gerard Buchanan, Paul Ringholz, Fiona |
author_facet | Urbach, Valérie Higgins, Gerard Buchanan, Paul Ringholz, Fiona |
author_sort | Urbach, Valérie |
collection | PubMed |
description | In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl(−) secretion and Na(+) hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this general description, the pathogenesis of CF lung disease remains obscure due to an incomplete understanding of normal innate airway defense. This mini-review aims to highlight the role of the pro-resolution lipid mediator, Lipoxin A(4), which is inadequately produced in CF, on several aspects of innate immunity that are altered in CF airway disease. |
format | Online Article Text |
id | pubmed-3962119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Research Network of Computational and Structural Biotechnology (RNCSB) Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-39621192014-03-31 The role of Lipoxin A4 in Cystic Fibrosis Lung Disease Urbach, Valérie Higgins, Gerard Buchanan, Paul Ringholz, Fiona Comput Struct Biotechnol J Review Article In Cystic Fibrosis (CF), mutations of the CFTR gene result in defective Cl(−) secretion and Na(+) hyperabsorption by epithelia which leads to airway lumen dehydration and mucus plugging and favours chronic bacterial colonization, persistent inflammation and progressive lung destruction. Beyond this general description, the pathogenesis of CF lung disease remains obscure due to an incomplete understanding of normal innate airway defense. This mini-review aims to highlight the role of the pro-resolution lipid mediator, Lipoxin A(4), which is inadequately produced in CF, on several aspects of innate immunity that are altered in CF airway disease. Research Network of Computational and Structural Biotechnology (RNCSB) Organization 2013-12-06 /pmc/articles/PMC3962119/ /pubmed/24688726 http://dx.doi.org/10.5936/csbj.201303018 Text en © Urbach et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. |
spellingShingle | Review Article Urbach, Valérie Higgins, Gerard Buchanan, Paul Ringholz, Fiona The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title | The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title_full | The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title_fullStr | The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title_full_unstemmed | The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title_short | The role of Lipoxin A4 in Cystic Fibrosis Lung Disease |
title_sort | role of lipoxin a4 in cystic fibrosis lung disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962119/ https://www.ncbi.nlm.nih.gov/pubmed/24688726 http://dx.doi.org/10.5936/csbj.201303018 |
work_keys_str_mv | AT urbachvalerie theroleoflipoxina4incysticfibrosislungdisease AT higginsgerard theroleoflipoxina4incysticfibrosislungdisease AT buchananpaul theroleoflipoxina4incysticfibrosislungdisease AT ringholzfiona theroleoflipoxina4incysticfibrosislungdisease AT urbachvalerie roleoflipoxina4incysticfibrosislungdisease AT higginsgerard roleoflipoxina4incysticfibrosislungdisease AT buchananpaul roleoflipoxina4incysticfibrosislungdisease AT ringholzfiona roleoflipoxina4incysticfibrosislungdisease |